ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
Top Cited Papers
Open Access
- 1 June 2017
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 35 (30), 3780-3788
- https://doi.org/10.1016/j.vaccine.2017.05.032
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Vaccines against Middle East respiratory syndrome coronavirus for humans and camelsReviews in Medical Virology, 2016
- Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in ChinaEmerging Microbes & Infections, 2016
- Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus ChallengeEBioMedicine, 2015
- A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primatesScience Translational Medicine, 2015
- Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi ArabiamBio, 2014
- Clinical applications of attenuated MVA poxvirus strainExpert Review of Vaccines, 2013
- Middle East Respiratory Syndrome Coronavirus Infections in Health Care WorkersThe New England Journal of Medicine, 2013
- A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative ImmunogenicityPLOS ONE, 2012
- Effective induction of high-titer antibodies by viral vector vaccinesNature Medicine, 2008
- Single-Dose Protection againstPlasmodium bergheiby a Simian Adenovirus Vector Using a Human Cytomegalovirus Promoter Containing Intron AJournal of Virology, 2008